Next Quarterly Earnings
Tuesday, November 17, 2026
CW 47
Pre-Market
In 82 days
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Immatics
Immatics is a leading Germany-based biopharmaceutical company specializing in the development of innovative cancer immunotherapies. By identifying specific tumor targets, Immatics develops novel T-cell receptor-based therapies designed to effectively combat cancer.
Frequently asked questions
When will Immatics report its next quarterly earnings?
Immatics is scheduled to report its next quarterly earnings on 11/17/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
When did Immatics last report quarterly earnings?
Immatics last reported quarterly earnings on 8/18/2026 (Q2 2026). Earnings per share (EPS) came in at -0.52 USD.
How does Immatics stock react to earnings?
Across its last 3 earnings reports, Immatics stock moved by ±1.1% on average the following day. The largest reaction was -1.7% on 08/18/2026; 0 of 3 reactions were positive.
How often has Immatics beaten expectations?
Immatics has beaten analyst EPS estimates in 1 of its last 5 evaluated quarters (beat rate: 20%).
How do I add the Immatics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±1.1%
Avg. next-day move
-1.7%
Largest move (08/18/2026)
0%
Share of positive reactions
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
1/5
Quarters above estimates
20%
Beat rate
+2.6%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.